Concepedia

Publication | Closed Access

Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib

DOI

83

Citations

23

References

2018

Year

Max J. Gordon, Michael C. Churnetski, Hamood Alqahtani, Xavier Rivera, Adam S. Kittai, Stephen M. Amrock, Spencer James, Sheila Hoff, Sudhir Manda, Stephen E. Spurgeon,
Cancer

Abstract

Comorbidities portend a poor prognosis among patients with CLL treated with ibrutinib. Prospective studies are needed to optimize the treatment of patients with CLL who have comorbidities. Cancer 2018. © 2018 American Cancer Society.

References

YearCitations

Page 1